-
Why BridgeBio Pharma (BBIO) Is Among the Best Mid Cap Biotech Stocks to Buy
29 Mar 2025 20:42 GMT
… to treat patients … FDA approval of its leading drug acoramidis, now branded as Attruby. Attruby treats … FDA approval. BridgeBio Pharma, Inc. (NASDAQ:BBIO) has another potential drug … drug in the pivotal-stage trial indicated for achondroplasia (short stature …
-
Soleno breaks through with FDA nod for Prader-Willi syndrome treatment Vykat XR
27 Mar 2025 23:10 GMT
… becomes the first drug to treat hyperphagia. It is … muscle tone, short stature and intellectual and developmental problems.
The … a phase 3 trial in which patients … Pharmaceuticals of San Diego is developing a treatment, intranasal carbetocin, which the FDA …
-
FDA Approves Diazoxide Choline Extended-Release Tablets in Prader-Willi Syndrome
27 Mar 2025 14:13 GMT
… in the clinical development program of DCCR, … low muscle tone, short stature, and an excessive accumulation … FDA granted breakthrough, fast track, and orphan drug designations for the treatment … double-blind, placebo-controlled trial. J Clin Endocrinol …
-
FDA approves diazoxide choline extended-release tablets for hyperphagia in Prader-Willi syndrome
27 Mar 2025 00:04 GMT
… was approved by the FDA to treat hyperphagia among individuals aged … approved treatment has been granted breakthrough, fast track, and orphan drug … low muscle tone, short stature, exccess body fat accumulation, developmental delays, and incomplete …
-
Natalia Grace's sad and bizarre adoption story gets the TV treatment
23 Mar 2025 20:32 GMT
… , in separate cases, over their treatment of Natalia.
Less than two … -year-old woman, using her short stature to pose as a child … in late 2022.
During the trial, prosecutors argued that the Barnetts … before Kristine Barnett's trial was set to start, her …
-
Recent R&D developments for biosolutions in agriculture
23 Mar 2025 13:20 GMT
… -optimal growth temperatures. Thus, biostimulant treatment can make agriculture more sustainable … technologies
Bayer Crop Science has developed ‘Short Stature Corn’, a hybrid crop that … spectrum of applications from seed treatment to post-harvest.
Contact:
…
-
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2024 Earnings Call Transcript
19 Mar 2025 12:21 GMT
… appropriate treatment. Since there are various causes of short stature, when … most of the doctors treating the condition, we … classified as a specialty medication that resulted in very … to pursue. Eton Pharmaceuticals, Inc. has developed a proprietary extended …
-
Most popular dog breeds in America
04 Apr 2025 13:41 GMT
… is the breed's short stature; the dog was bred … made them great at competitions, drug detection, and search-and- … and exercise, otherwise they may develop destructive and neurotic behaviors.
… and rescue, herding, and drug detection. These dogs tend to …
-
Top Driver In Nutropin Aq Market 2025: Rising Research And Development Investments To Propel The Market
12 Mar 2025 12:25 GMT
… o Increased demand for treatments addressing short stature.
o Growing adoption … :
• Advancements in biosimilar development.
• Adoption of innovative … Distribution Channel: Hospital Pharmacies, Specialty Pharmacies, Online Pharmacies.
Which Regions Have …
-
Rare Disease Day: seven drugs awaiting approval in 2025
28 Feb 2025 16:13 GMT
… Organization. Treating these … such as short stature, floppiness … FDA.
Fitusiran
Fitusiran is an investigational siRNA therapy for the prophylactic treatment … trial, which was revealed last year. The drug developer Massachusetts-based KalVista Pharmaceuticals …